美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国抗疫概念

1,461.96

-8.3567-0.57%

涨家数：8

跌家数：12

平家数：- -

市盈率：- -

高：1,469.90

开：1,469.76

低：1,461.77

收：1,470.19

数据加载中...

总览新闻资讯

Ocugen, Inc.盘中异动快速跳水5.09%报0.619美元

吉利德科学公司预留 2 亿美元解决艾滋病药物调查问题

辉瑞公司首席执行官表示，辉瑞可能将外部生产基地迁至美国

辉瑞(PFE.N)高管：如果有显著的关税，公司将努力将制造业务转移至美国。

Ibio, Inc.盘中异动早盘股价大涨6.00%报6.18美元

高盛将阿斯利康、诺和诺德、力拓纳入其欧洲“确信名单”。

第一三共/阿斯利康(AZN.US)重磅ADC疗法有望再获欧盟批准

高风险下的投资红灯已亮，避开TSLA、MRNA

强生(JNJ.US)自免领域再落重子

智通财经网

核心产品“过气” 真实生物二度赴港IPO

Ocugen, Inc.盘中异动快速上涨5.24%报0.642美元

Ibio, Inc.盘中异动早盘大幅下挫5.15%报4.79美元

Aethlon Medical, Inc.盘中异动早盘股价大跌5.18%报0.531美元

诺瓦瓦克斯医药盘中异动早盘快速拉升5.38%

英国卫生监管机构批准为 60 岁及以上人群接种 Moderna 的 RSV 疫苗

吉利德的中年困境：抱住CAR-T的浮木

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1461.8291,"timestamp":1741272159358,"preClose":1470.1858,"halted":0,"volume":6526982,"delay":0,"changeRate":-0.005684,"change":-8.356689,"pbRate":4.026038,"amount":322534525.834638,"amplitude":0.005533,"prevYearClose":1274.8187,"fiveDayClose":1446.7607,"twentyDayClose":1373.9138,"turnoverRate":0.000422,"marketCap":1206247371660.5,"floatMarketCap":1183866993602,"peRate":31.895692},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1469.9016,"amplitude":0.005533,"preClose":1470.1858,"low":1461.7671,"pbRate":"4.026038","latestPrice":1461.9625,"volume":6524292,"delay":0,"open":1469.7611,"prevYearClose":1274.8187,"prevWeekClose":1463.5875,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1446.7607,"twentyDayClose":1373.9138,"sixtyDayClose":1299.5834,"secType":"PLATE","market":"US","turnoverRate":0.000422,"peRate":31.895692,"marketCap":1206405225356.5,"floatMarketCap":1184022334402,"timestamp":1741272158099,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":8,"down":12,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516652894","title":"Ocugen, Inc.盘中异动 快速跳水5.09%报0.619美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516652894?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 02:28","pubTimestamp":1741026501,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时28分，Ocugen, Inc.股票出现波动，股价急速跳水5.09%。截至发稿，该股报0.619美元/股，成交量213.938万股，换手率0.74%，振幅7.01%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022821abe677b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022821abe677b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCGN","BK4139","BK4568","BK4563"],"gpt_icon":0},{"id":"2516965363","title":"吉利德科学公司预留 2 亿美元解决艾滋病药物调查问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2516965363","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516965363?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 00:18","pubTimestamp":1741018714,"startTime":"0","endTime":"0","summary":"路透社纽约3月3日 - 吉利德科学公司预留了2亿美元用于与联邦检察官可能达成的和解，以解决对该制药公司HIV药物促销扬声器计划的调查。吉利德公司说，它在2017年收到了传票，但在文件中没有提供有关调查的更多细节。曼哈顿联邦检察官办公室发言人拒绝发表评论。2024 年第四季度，吉利德公司的艾滋病药物销售额增长了 16% ，达到 54.5 亿美元，促使其股价飙升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nL3S3PM18K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU0289739699.SGD","LU0109394709.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4583","BK4585","LU1066053197.SGD","LU0889565916.HKD","IE00B19Z3B42.SGD","LU2089984988.USD","LU2468319806.SGD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","IE0002270589.USD","BK4532","GILD","LU1839511570.USD","BK4139","LU1430594728.SGD","LU1571399168.USD","IE00B3T34201.USD","BK4566","BK4550","IE00B19Z3581.USD","BK4568","BK4578","LU1585245621.USD","LU0234570918.USD","LU2087621335.USD","LU1066051498.USD","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2516658185","title":"辉瑞公司首席执行官表示，辉瑞可能将外部生产基地迁至美国","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658185","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516658185?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 23:56","pubTimestamp":1741017395,"startTime":"0","endTime":"0","summary":"辉瑞公司首席执行官表示，辉瑞可能将外部生产基地迁至美国路透社3月3日 - 辉瑞PFE.N首席执行官阿尔伯特-布尔拉（Albert Bourla）周一表示，由于唐纳德-特朗普（Donald Trump）总统的政府威胁要对进口商品征收大量关税，制药商可能会在必要时将海外生产转移到美国。 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nL3T3PM175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU1023059063.AUD","SG9999002232.USD","BK4592","LU0456855351.SGD","BK4581","LU0234572021.USD","LU0868494617.USD","LU1066053197.SGD","IE00BBT3K403.USD","LU0225284248.USD","LU0306807586.USD","LU0985481810.HKD","IE000M9KFDE8.USD","LU1894683348.USD","LU0306806265.USD","LU0170899867.USD","SG9999011175.SGD","BK4550","BK4588","LU0289739699.SGD","LU0058720904.USD","LU1894683264.USD","SGXZ57979304.SGD","LU0225771236.USD","SG9999003800.SGD","LU0122379950.USD","LU0321505439.SGD","BK4585","IE00BLSP4452.SGD","BK4568","PFE","IE00BLSP4239.USD","IE00B19Z3B42.SGD","SG9999001176.USD","BK4534","BK4533","BK4599","LU0321505868.SGD","SG9999013999.USD","SG9999001176.SGD","BK4007","LU1883839398.USD","IE00B19Z3581.USD","IE0002270589.USD","SG9999002224.SGD","LU1066051498.USD"],"gpt_icon":0},{"id":"2516163074","title":"辉瑞(PFE.N)高管：如果有显著的关税，公司将努力将制造业务转移至美国。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516163074","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516163074?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 23:39","pubTimestamp":1741016341,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4534","SGXZ57979304.SGD","LU0321505868.SGD","LU0058720904.USD","BK4581","LU0225284248.USD","LU0234572021.USD","LU1023059063.AUD","LU0170899867.USD","LU1057294990.SGD","BK4568","LU1066053197.SGD","LU1894683348.USD","IE00BBT3K403.USD","LU0306807586.USD","SG9999002232.USD","LU1883839398.USD","IE00B19Z3B42.SGD","SG9999011175.SGD","IE00B19Z3581.USD","BK4599","SG9999002224.SGD","IE00BLSP4452.SGD","SG9999003800.SGD","BK4533","BK4550","LU1894683264.USD","IE0002270589.USD","LU0985481810.HKD","BK4588","BK4592","IE000M9KFDE8.USD","LU0225771236.USD","BK4007","PFE","SG9999001176.SGD","LU0306806265.USD","LU1066051498.USD","LU0289739699.SGD","LU0321505439.SGD","IE00BLSP4239.USD","SG9999013999.USD","SG9999001176.USD","LU0456855351.SGD","LU0122379950.USD","LU0868494617.USD","BK4585"],"gpt_icon":0},{"id":"2516347676","title":"Ibio, Inc.盘中异动 早盘股价大涨6.00%报6.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516347676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516347676?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 22:34","pubTimestamp":1741012470,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时34分，Ibio, Inc.股票出现异动，股价急速上涨6.00%。截至发稿，该股报6.18美元/股，成交量14.6236万股，换手率1.48%，振幅8.92%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223430989a1038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223430989a1038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","IBIO","BK4139"],"gpt_icon":0},{"id":"2516936572","title":"高盛将阿斯利康、诺和诺德、力拓纳入其欧洲“确信名单”。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516936572","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516936572?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 13:59","pubTimestamp":1740981553,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["AZN","IE00B19Z3581.USD","LU2237443895.HKD","LU0345780950.USD","LU2417539215.USD","IE0004086264.USD","RIO","LU0788109121.HKD","NVO","IE00B3M56506.USD","IE00BFXG1179.USD","IE00BZ1G4Q59.USD","LU0345777147.USD","LU2237443622.USD","LU1130305938.SGD","LU0154236417.USD","LU1078025761.USD","BK4533","LU1868836591.USD","IE00BWDBJ516.SGD","LU1668664300.SGD","LU1868836914.USD","LU0096364046.USD","BK4168","LU0654597011.USD","LU2236285917.USD","LU1829250122.USD","LU2237443549.SGD","LU1868837136.USD","BK4588","LU0505663152.USD","LU2750360997.AUD","RIO.UK","LU0955669360.SGD","IE00BSNM7G36.USD","IE0034235071.USD","LU2471134879.HKD","IE0034235188.USD","LU2471134796.USD","LU2237438978.USD","BK4550","BK4532","LU2471134952.CNY","BK4568","LU1023059493.AUD","IE00BKVL7J92.USD","LU0171293334.USD","LU0889565916.HKD","LU2237443465.HKD","LU0109394709.USD"],"gpt_icon":0},{"id":"2516578625","title":"第一三共/阿斯利康(AZN.US)重磅ADC疗法有望再获欧盟批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2516578625","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516578625?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 10:46","pubTimestamp":1740969968,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，日前，第一三共与阿斯利康共同宣布，其联合开发的重磅抗体偶联药物Enhertu获得欧洲药品管理局人用药品委员会推荐在欧盟获批，作为单药用于治疗不可切除或转移性激素受体阳性、HER2低表达或HER2极低表达的乳腺癌成人患者，这些患者至少接受过一种内分泌疗法治疗转移性癌症，且被认为不适合接受内分泌疗法作为下一线治疗。据悉，Enhertu是首款具有不限癌种适应症的HER2靶向ADC疗法。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","BK4588","AZN","LU2417539215.USD","LU0320765992.SGD","LU1829250122.USD","BK4007","LU0889565916.HKD","BK4231","BK4585","LU2462157665.USD","BK4568","LU2236285917.USD","ADC","LU2456880835.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2516578166","title":"高风险下的投资红灯已亮，避开TSLA、MRNA","url":"https://stock-news.laohu8.com/highlight/detail?id=2516578166","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516578166?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 10:11","pubTimestamp":1740967864,"startTime":"0","endTime":"0","summary":"根据Payne Capital Management高级财富顾问Courtney Garcia的说法，特斯拉和Moderna今年以来的疲软走势不会很快结束。特斯拉的股价自12月创下历史新高以来下跌了42%，受到销售放缓的影响。今年迄今，股价已经下跌了约30%，抹去了与选举相关的兴奋情绪。这位顾问指出，Moderna的主要收入来源是其新冠疫苗，而对该公司mRNA技术管线的投资尚未实现盈利。由于新冠疫苗需求下降，Moderna的疫苗销售下滑，股价今年已下跌了25%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/03/03101148478375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0823414478.USD","LU1720051017.SGD","LU2750360997.AUD","LU0820561909.HKD","LU2756315664.SGD","BK4598","LU1720051108.HKD","BK4585","LU2213496289.HKD","LU2360107168.USD","LU1674673428.USD","MRNA","LU0316494557.USD","LU0345770993.USD","BK4551","LU0234572021.USD","LU1066051225.USD","BK4527","LU0097036916.USD","IE00BK4W5M84.HKD","BK4533","LU2360106780.USD","BK4568","LU0345769128.USD","BK4588","IE00BSNM7G36.USD","IE00BJLML261.HKD","LU2471134952.CNY","LU2750360641.GBP","TSLA","BK4534","IE00BK4W5L77.USD","LU1551013425.SGD","LU2023250330.USD","LU2290526834.HKD","IE00B1XK9C88.USD","LU1861558580.USD","BK4555","LU1066051498.USD","BK4099","LU0466842654.USD","LU1778281490.HKD","LU1861559042.SGD","LU2087621335.USD","LU2250418816.HKD","LU1629891620.HKD","TSYW.SI","LU1839511570.USD","SG9999015986.USD","LU0820562030.AUD"],"gpt_icon":1},{"id":"2516156246","title":"强生(JNJ.US)自免领域再落重子","url":"https://stock-news.laohu8.com/highlight/detail?id=2516156246","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516156246?lang=zh_cn&edition=fundamental","pubTime":"2025-03-02 07:19","pubTimestamp":1740871184,"startTime":"0","endTime":"0","summary":"旗下古塞奇尤单抗注射液成功获得NMPA批准","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20250302/20250302072252_94998.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250302/20250302072252_94998.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4534","IE00BVYPNV92.GBP","LU2089984988.USD","JNJ","LU1280957306.USD","LU2133065610.SGD","LU2602419157.SGD","LU1066053197.SGD","LU1267930813.SGD","IE00B19Z3581.USD","LU0289739699.SGD","LU1221951046.USD","IE00B1BXHZ80.USD","BK4504","LU1244550577.SGD","LU1935042991.SGD","LU2112291526.USD","LU2129689605.HKD","IE00BJT1NW94.SGD","LU1196500208.SGD","IE00BFTCPJ56.SGD","LU0795875169.SGD","LU0912757837.SGD","BK4568","IE00BGHQF631.EUR","LU0058720904.USD","LU1059921491.USD","LU2347655156.SGD","SG9999002224.SGD","LU0203345920.USD","LU1718418525.SGD","LU0098860793.USD","BK4532","LU1061106388.HKD","LU2129689431.USD","LU0320765646.SGD","LU1894683264.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","BK4559","IE00BVYPNW00.USD","LU1929549753.HKD","LU0795875086.SGD","BK4550","IE00B42XCP33.USD","LU1430594728.SGD","BK4533"],"gpt_icon":0},{"id":"2516305777","title":"核心产品“过气”  真实生物二度赴港IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2516305777","media":"贝果财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516305777?lang=zh_cn&edition=fundamental","pubTime":"2025-03-01 03:45","pubTimestamp":1740771900,"startTime":"0","endTime":"0","summary":"近期，真实生物再度冲刺港股上市，靠的仍是同一款产品。2023年及2024年，真实生物全部收入均来自阿兹夫定，公司在此期间持续亏损。事实上，真实生物前次IPO亦处在亏损状态。随后，真实生物与53家经销商订立协议。真实生物方面表示，公司预计未来会继续产生大额研发费用。杜锦发曾公开表示，完成B轮融资后，真实生物也将启动港股IPO的进程。真实生物前次IPO募资主要用于阿兹夫定治疗COVID-19的制造和商业化，以及采购阿兹夫定医药原料。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-03-01/doc-inenarnx1885137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK4139","600196","BNTX","BK0183","BK0012","BK1191","02196","BK0196","BK1515","BK1593","BK4588","BK0175","BK4585","BK4551","BK4568","BK4548","BK0028","BK0187","BK0096","BK0188","BK0060","BK4535"],"gpt_icon":0},{"id":"2516337733","title":"Ocugen, Inc.盘中异动 快速上涨5.24%报0.642美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516337733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516337733?lang=zh_cn&edition=fundamental","pubTime":"2025-03-01 01:18","pubTimestamp":1740763133,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日01时18分，Ocugen, Inc.股票出现波动，股价大幅拉升5.24%。截至发稿，该股报0.642美元/股，成交量158.93万股，换手率0.55%，振幅6.54%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301011853abe111b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301011853abe111b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCGN","BK4563","BK4568","BK4139"],"gpt_icon":0},{"id":"2514731543","title":"Ibio, Inc.盘中异动 早盘大幅下挫5.15%报4.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514731543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514731543?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 22:56","pubTimestamp":1740754616,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时56分，Ibio, Inc.股票出现波动，股价大幅跳水5.15%。截至发稿，该股报4.79美元/股，成交量27.218万股，换手率2.76%，振幅7.92%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225656abe0f146&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225656abe0f146&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBIO","BK4568"],"gpt_icon":0},{"id":"2514785593","title":"Aethlon Medical, Inc.盘中异动 早盘股价大跌5.18%报0.531美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514785593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514785593?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 22:35","pubTimestamp":1740753352,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时35分，Aethlon Medical, Inc.股票出现波动，股价快速下挫5.18%。截至发稿，该股报0.531美元/股，成交量8451股，换手率0.06%，振幅1.02%。Aethlon Medical, Inc.股票所在的医疗器械行业中，整体涨幅为0.39%。其相关个股中，Monogram Technologies Inc.、Heartsciences Inc.、沃氪医疗涨幅较大，Rapid Micro Biosystems, Inc.、Dih Holding Us, Inc.、沃氪医疗较为活跃，换手率分别为15.08%、4.00%、2.46%，振幅较大的相关个股有Envveno Medical Corporation、Butterfly Network, Inc.、Ainos, Inc.，振幅分别为17.56%、10.19%、8.94%。Aethlon Medical, Inc.公司简介：Aethlon Medical Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223552abe0ec00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223552abe0ec00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4568","BK4082","AEMD"],"gpt_icon":0},{"id":"2514378509","title":"诺瓦瓦克斯医药盘中异动 早盘快速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514378509?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 22:33","pubTimestamp":1740753180,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时33分，诺瓦瓦克斯医药股票出现波动，股价快速拉升5.38%。截至发稿，该股报7.44美元/股，成交量28.2614万股，换手率0.18%，振幅3.82%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.05%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。该公司认为，其疫苗技术有可能广泛应用于各种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223300a25801b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223300a25801b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4139","BK4568","BK4585","BK4588","NVAX"],"gpt_icon":0},{"id":"2514342384","title":"英国卫生监管机构批准为 60 岁及以上人群接种 Moderna 的 RSV 疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2514342384","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514342384?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 18:48","pubTimestamp":1740739706,"startTime":"0","endTime":"0","summary":"英国卫生监管机构批准为 60 岁及以上人群接种 Moderna 的 RSV 疫苗路透社2月28日 - 英国卫生监管机构周五表示，已批准Moderna公司的MRNA.O疫苗用于保护60岁及以上患者免受由呼吸道合胞病毒(RSV) 引起的下呼吸道疾病的侵袭。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL3S3PJ0UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","BK4551","BK4548","BK4568","BK4585","BK4588","MRNA","BK4534","BK4532","BK4533","BK4139"],"gpt_icon":0},{"id":"2514037597","title":"吉利德的中年困境：抱住CAR-T的浮木","url":"https://stock-news.laohu8.com/highlight/detail?id=2514037597","media":"深蓝观","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514037597?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 18:48","pubTimestamp":1740739680,"startTime":"0","endTime":"0","summary":"2017年收购CAR-T巨头公司Kite是吉利德正式进入肿瘤治疗领域的标志。在拓展新领域之前，吉利德优势明显的依然是HIV和CAR-T领域，这也是吉利德布局的重点。在吉利德试水过的多个领域中，CAR-T俨然是目前最拿得出手的招牌。吉利德现在的当务之急是准备补充新一代CAR-T管线。吉利德于2020年3月收购的CD47单抗Magrolimab因安全性问题终止研发，49亿美元的投资打水漂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231011abe0f449&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231011abe0f449&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","GILD","BK4139","BK4230","LU0109394709.USD","IE00B3T34201.USD","IE00B19Z3581.USD","LU0058720904.USD","LU1585245621.USD","LU0234570918.USD","BK4583","BK4568","IE00BSNM7G36.USD","IE0002270589.USD","BK4550","IE00B19Z3B42.SGD","BK4585","LU1571399168.USD","BK4566","LU2087621335.USD","LU1066051498.USD","LU2089984988.USD","LU0320765992.SGD","CAR","BK4578","LU1430594728.SGD","BK4532","LU1839511570.USD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4588","LU0889565916.HKD","LU1066053197.SGD","LU2468319806.SGD","BK4022"],"gpt_icon":0}],"pageSize":16,"totalPage":10,"pageCount":3,"totalSize":153}]}}